Second primary malignancies in head and neck cancer patients: High prevalence of curable-stage disease

Strahlentherapie und Onkologie

Volumn 189, Issue 10, 2013, Pages 874-880

  Wolff, H A ^a   Wolff, C R M ^a   Hess, C F ^a   Jung, K ^a   Sennhenn Kirchner, S ^a   Hinterthaner, M ^a   Muller Dornieden A ^a   Korber W ^b   Marten Engelke, K ^a   Roedel, R ^a   Christiansen, H ^a,c   Engelke, C ^a  

^a UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

^b Sleep Laboratory   (Germany)

^c HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Carcinoma; Low dose CT; Neoplasms; Radiochemotherapy; Screening; second primary; squamous cell of head and neck

Indexed keywords

ANTINEOPLASTIC AGENT; CONTRAST MEDIUM;

ADENOCARCINOMA; ADULT; ARTICLE; ASPERGILLOMA; BRONCHOSCOPY; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER LOCALIZATION; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER RISK; CANCER SURGERY; CANCER SURVIVAL; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; COST EFFECTIVENESS ANALYSIS; ENDOSCOPY; ESOPHAGOSCOPY; FEMALE; GASTROSCOPY; GRANULOMA; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HISTOPATHOLOGY; HUMAN; KIDNEY CARCINOMA; LUNG SMALL CELL CANCER; LUNG SQUAMOUS CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; NOSE; NUCLEAR MAGNETIC RESONANCE IMAGING; OTOSCOPY; PREVALENCE; SECOND CANCER; SQUAMOUS CELL CARCINOMA; THROAT; VIDEO ASSISTED THORACOSCOPIC SURGERY;

ADULT; AGED; CARCINOMA, SQUAMOUS CELL; GERMANY; HEAD AND NECK NEOPLASMS; HUMANS; MIDDLE AGED; NEOPLASMS, MULTIPLE PRIMARY; PREVALENCE; RADIOTHERAPY, CONFORMAL; RISK ASSESSMENT; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 84887306491     PISSN: 01797158     EISSN: 1439099X     Source Type: Journal    
DOI: 10.1007/s00066-013-0404-4     Document Type: Article

References (29)

1. Aberle DR, Adams AM, Berg CD et al (2011) Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med 365:395-409
2. Bradley PJ, Bradley PT (2010) Searching for metachronous tumours in patients with head and neck cancer: the ideal protocol! Curr Opin Otolaryngol Head Neck Surg 18:124-133
3. Chin D, Boyle GM, Porceddu S et al (2006) Head and neck cancer: past, present and future. Expert Rev Anticancer Ther 6:1111-1118
4. Christiansen H, Hermann RM, Martin A et al (2006) Long-term follow-up after transoral laser microsurgery and adjuvant radiotherapy for advanced recurrent squamous cell carcinoma of the head and neck. Int J Radiat Oncol Biol Phys 65:1067-1074
5. Corvo R (2007) Evidence-based radiation oncology in head and neck squamous cell carcinoma. Radiother Oncol 85:156-170
6. Deantonio L, Masini L, Brambilla M et al (2013) Dysphagia after definitive radiotherapy for head and neck cancer: correlation of dose-volume parameters of the pharyngeal constrictor muscles. Strahlenther Onkol 189:230-236
7. Gao Y, Hu N, Han XY et al (2011) Risk factors for esophageal and gastric cancers in Shanxi Province, China: a case-control study. Cancer Epidemiol 35:e91-e99
8. Henschke CI, McCauley DI, Yankelevitz DF et al (2001) Early lung cancer action project: a summary of the findings on baseline screening. Oncologist 6:147-152
9. Hernandez-Boluda JC, Pereira A, Cervantes F et al (2012) A polymorphism in the XPD gene predisposes to leukemic transformation and new nonmyeloid malignancies in essential thrombocythemia and polycythemia vera. Blood 119:5221-5228
10. Hess CF, Kortmann RD, Schmidberger H, Bamberg M (1994) How relevant is secondary leukaemia for initial treatment selection in Hodgkin's disease? Eur J Cancer 30A:1441-1447
11. Kazi R, Manikanthan K, Pathak KA, Dwivedi RC (2010) Head and neck squamous cell cancers: need for an organised time-bound surveillance plan. Eur Arch Otorhinolaryngol 267:1969-1971
12. Koshy M, Rich SE, Mahmood U, Kwok Y (2012) Declining use of radiotherapy in stage I and II Hodgkin's disease and its effect on survival and secondary malignancies. Int J Radiat Oncol Biol Phys 82:619-625
13. Lee KD, Lu CH, Chen PT et al (2009) The incidence and risk of developing a second primary esophageal cancer in patients with oral and pharyngeal carcinoma: a population-based study in Taiwan over a 25 year period. BMC Cancer 9:373
14. Leon X, Quer M, Diez S et al (1999) Second neoplasm in patients with head and neck cancer. Head Neck 21:204-210
15. MacMahon H, Austin JH, Gamsu G et al (2005) Guidelines for management of small pulmonary nodules detected on CT scans: a statement from the Fleischner Society. Radiology 237:395-400
16. Olthoff A, Ewen A, Wolff HA et al (2009) Organ function and quality of life after transoral laser microsurgery and adjuvant radiotherapy for locally advanced laryngeal cancer. Strahlenther Onkol 185:303-309
17. Pelucchi C, Tramacere I, Boffetta P et al (2011) Alcohol consumption and cancer risk. Nutr Cancer 63:983-990
18. Petit T, Georges C, Jung GM et al (2001) Systematic esophageal endoscopy screening in patients previously treated for head and neck squamous-cell carcinoma. Ann Oncol 12:643-646
19. Rades D, Meyners T, Kazic N et al (2011) Comparison of radiochemotherapy alone to surgery plus radio(chemo)therapy for non-metastatic stage III/IV squamous cell carcinoma of the head and neck: a matched-pair analysis. Strahlenther Onkol 187:541-547
20. Rades D, Ulbricht T, Hakim SG, Schild SE (2012) Cisplatin superior to carboplatin in adjuvant radiochemotherapy for locally advanced cancers of the oropharynx and oral cavity. Strahlenther Onkol 188:42-48
21. Rodel RM, Steiner W, Muller RM et al (2009) Endoscopic laser surgery of early glottic cancer: involvement of the anterior commissure. Head Neck 31:583-592
22. Sciubba JJ (2001) Oral cancer. The importance of early diagnosis and treatment. Am J Clin Dermatol 2:239-251
23. Simon C, Plinkert PK (2008) Combined modality approaches in the treatment of head and neck cancer patients. HNO 56:575-584
24. Swensen SJ, Jett JR, Sloan JA et al (2002) Screening for lung cancer with low-dose spiral computed tomography. Am J Respir Crit Care Med 165:508-513
25. Tribius S, Sommer J, Prosch C et al (2013) Xerostomia after radiotherapy: what matters-mean total dose or dose to each parotid gland? Strahlenther Onkol 189:216-222
26. Tsou YA, Hua CH, Tseng HC et al (2007) Survival study and treatment strategy for second primary malignancies in patients with head and neck squamous cell carcinoma and nasopharyngeal carcinoma. Acta Otolaryngol 127:651-657
27. Weiderpass E (2010) Lifestyle and cancer risk. J Prev Med Public Health 43:459-471
28. Wolff HA, Bosch J, Jung K et al (2010) High-grade acute organ toxicity as positive prognostic factor in primary radio(chemo)therapy for locally advanced, inoperable head and neck cancer. Strahlenther Onkol 186:262-268
29. Wolff HA, Overbeck T, Roedel RM et al (2009) Toxicity of daily low dose cisplatin in radiochemotherapy for locally advanced head and neck cancer. J Cancer Res Clin Oncol 135:961-967